Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangqi Peng

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chemistry, an Asian Journal|February 27, 2021
CRISPR-Cas12a System for Biosensing and Gene RegulationYuyan Shi, Xiaoyi Fu, Yao Yin, et al.
Nature Communications|April 7, 2020
Size-selective molecular recognition based on a confined DNA molecular sieve using cavity-tunable framework nucleic acidsXiaoyi Fu, Guoliang Ke, Fangqi Peng, et al.
Chemical Research in Chinese Universities|January 23, 2023
Construction and Application of DNAzyme-based NanodevicesBo Wang, Menghui Wang, Fangqi Peng, et al.
Analytical Chemistry|March 11, 2021
Exploring the Trans-Cleavage Activity of CRISPR/Cas12a on Gold Nanoparticles for Stable and Sensitive BiosensingXiaoyi Fu, Yuyan Shi, Fangqi Peng, et al.
Topics in Current Chemistry (Cham)|February 8, 2020
Aptamer-Functionalized DNA Nanostructures for Biological ApplicationsXiaoyi Fu, Fangqi Peng, Jungyeon Lee, et al.
International Journal of Nanomedicine|August 8, 2015
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomesWendian Zhang, Fangqi Peng, Taotao Zhou, et al.
Chemical Communications (Cambridge, England)|March 3, 2021
Size-selective DNA nanocage-based activatable CRISPR-Cas12a for sensitive and accurate detection of mature microRNAXiaoyi Fu, Yao Yin, Meng Zhang, et al.
Cell|April 18, 2026
p53 safeguards chemical reprogramming of human somatic cells toward pluripotencyLin Cheng, Yanglu Wang, Zhihan Yang, et al.
Cell Discovery|December 23, 2025
Robust generation of clinically applicable human pluripotent stem cells from peripheral blood by chemical reprogrammingXiaodi Fu, Fangqi Peng, Ruyi Cai, et al.
Cell Research|January 16, 2026
Efficient chemical reprogramming of human T cells to pluripotent stem cellsYanglu Wang, Fangqi Peng, Ruoqi Cheng, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chemistry, an Asian Journal|February 27, 2021
CRISPR-Cas12a System for Biosensing and Gene RegulationYuyan Shi, Xiaoyi Fu, Yao Yin, et al.
Nature Communications|April 7, 2020
Size-selective molecular recognition based on a confined DNA molecular sieve using cavity-tunable framework nucleic acidsXiaoyi Fu, Guoliang Ke, Fangqi Peng, et al.
Chemical Research in Chinese Universities|January 23, 2023
Construction and Application of DNAzyme-based NanodevicesBo Wang, Menghui Wang, Fangqi Peng, et al.
Analytical Chemistry|March 11, 2021
Exploring the Trans-Cleavage Activity of CRISPR/Cas12a on Gold Nanoparticles for Stable and Sensitive BiosensingXiaoyi Fu, Yuyan Shi, Fangqi Peng, et al.
Topics in Current Chemistry (Cham)|February 8, 2020
Aptamer-Functionalized DNA Nanostructures for Biological ApplicationsXiaoyi Fu, Fangqi Peng, Jungyeon Lee, et al.
International Journal of Nanomedicine|August 8, 2015
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomesWendian Zhang, Fangqi Peng, Taotao Zhou, et al.
Chemical Communications (Cambridge, England)|March 3, 2021
Size-selective DNA nanocage-based activatable CRISPR-Cas12a for sensitive and accurate detection of mature microRNAXiaoyi Fu, Yao Yin, Meng Zhang, et al.
Cell|April 18, 2026
p53 safeguards chemical reprogramming of human somatic cells toward pluripotencyLin Cheng, Yanglu Wang, Zhihan Yang, et al.
Cell Discovery|December 23, 2025
Robust generation of clinically applicable human pluripotent stem cells from peripheral blood by chemical reprogrammingXiaodi Fu, Fangqi Peng, Ruyi Cai, et al.
Cell Research|January 16, 2026
Efficient chemical reprogramming of human T cells to pluripotent stem cellsYanglu Wang, Fangqi Peng, Ruoqi Cheng, et al.
Pageof 2